Thomas Crawford, MD

Thomas Crawford, MD, discusses recent data for apitegromab for SMA, as well as overall developments in the field.

Thomas Crawford, MD, said SAPPHIRE trial data show apitegromab provides clinically meaningful strength gains for children with SMA by targeting muscle in addition to motor neurons.